Search Results
Baxter Increases Dividend and Declares Quarterly Dividend
Baxter International Inc. (NYSE:BAX), a leading global medical products company, today announced an increase in the company’s quarterly cash dividend, to a rate of $0.22 per share of common stock. This represents an approximately 16% increase over the previous quarterly dividend rate of $0.19 per share. Baxter’s Board of Directors declared the dividend payable on July 1, 2019, to stockholders of record as of June 7, 2019.
Baxter Named a 'Best Company For Multicultural Women' by Working Mother
Baxter International Inc. (NYSE:BAX), a leading global medical products company, announced today that it has been named a 2019 Best Company for Multicultural Women by Working Mother magazine. This recognition is a result of the company’s sustained focus on supporting and advancing multicultural women at all levels of the organization globally.
Baxter to Present at the UBS Global Healthcare Conference
Baxter International Inc. (NYSE:BAX), a leading global medical products company, will present at the UBS Global Healthcare Conference on Monday, May 20, 2019 in New York. Jay Saccaro, Baxter's chief financial officer, is scheduled to present at 1:00 p.m. Eastern Time. The live webcast of Baxter’s presentation can be accessed at www.baxter.com and will be available for replay through November 15, 2019.
Baxter, NAACP and the Alliance For Home Dialysis Expand Program to Increase Awareness of Kidney Care Among African Americans
Baxter International Inc. (NYSE:BAX), a global leader in renal care, along with the National Association for the Advancement of Colored People (NAACP) and the Alliance for Home Dialysis, today announced that the Dialysis Health Imperative for Access, Choice, and Equity (ACE) program will be expanded for a third year.
Baxter Reports First-Quarter 2019 Results
Baxter International Inc. (NYSE:BAX), a leading global medical products company, today reported results for the first quarter of 2019 and increased its full-year 2019 earnings outlook.
Baxter to Present at the Bank of America Merrill Lynch Health Care Conference 2019
Baxter International Inc. (NYSE:BAX), a leading global medical products company, will present at the 2019 Bank of America Merrill Lynch Health Care Conference in Las Vegas on May 15, 2019. Jay Saccaro, Baxter’s chief financial officer, is scheduled to present at 8:40 a.m. Pacific Time. The live webcast of Baxter’s presentation can be accessed at www.baxter.com and will be available for replay through November 11, 2019.
Baxter Unveils the Latest Evolution of Floseal at AORN Meeting
Baxter International Inc. (NYSE:BAX), a global leader in advancing surgical innovation, today announced that it has received U.S. Food and Drug Administration (FDA) approval for faster preparation of its leading hemostatic product, Floseal Hemostatic Matrix, at the 2019 Association of periOperative Registered Nurses (AORN) Global Surgical Conference and Expo.
Baxter to Host Webcast of Annual Meeting of Stockholders
Baxter International Inc. (NYSE:BAX), a leading global medical products company, will host a webcast of its Annual Meeting of Stockholders on Tuesday, May 7, 2019 at 9 a.m. Central Daylight Time.
Baxter Highlights Advancements in Clinical Nutrition at ASPEN Conference
Baxter International Inc. (NYSE:BAX), a global leader in clinical nutrition, today announced it will launch Clinolipid (20% Lipid Injectable Emulsion), its proprietary olive oil-based lipid emulsion, in the U.S. later this year — marking the growth of Baxter's lipid portfolio.
Confidence in the Wake of Natural Disaster
Through remote patient technology, nurses were able to stay connected with peritoneal dialysis patients after an earthquake.